Related Experiment Video
Updated: Mar 2, 2026

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
Published on: March 16, 2022
Interferon alpha-2a as alternative treatment for conjunctival squamous cell carcinoma
D Cruzado-Sánchez1, M Salas-Diaz2, W A Tellez3
1Servicio de Oftalmología Oncológica, Departamento de Cabeza y Cuello, Instituto Nacional de Enfermedades Neoplásicas (INEN), Perú.
Case Report:
A 35 year-old male patient with a history of HIV infection characterized by progressive tumour growth in bulbar conjunctiva of the left eye, corresponding to conjunctival squamous cell carcinoma that responded to treatment with interferon alpha-2a.
Discussion:
Interferon alpha-2b has been used at conjunctival level as a topical immunomodulator treatment, with complete remission of epithelial neoplasms being observed. However, there have not been any previous publications on the use of interferon alpha-2a, which differs from interferon alpha-2b in a single amino acid, for the treatment of conjunctival squamous cell carcinoma.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Tumor Immunotherapy

